# Fulgent Genetics, Inc. (FLGT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/FLGT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 156.53M | $ -54.36M | $ -25.72M | $ 9.42M | $ 1.00B |
| 2025 | $ 330.39M | $ -61.96M | $ -127.18M | $ 7.68M | $ 1.11B |
| 2024 | $ 297.95M | $ -44.89M | $ -20.24M | $ 8.47M | $ 1.13B |
| 2023 | $ 312.71M | $ -181.46M | $ 5.19M | $ 15.25M | $ 1.14B |
| 2022 | $ 691.45M | $ 160.20M | $ 262.24M | $ 38.94M | $ 1.27B |
| 2021 | $ 1.18B | $ 603.08M | $ 611.88M | $ 21.28M | $ 1.16B |
| 2020 | $ 537.23M | $ 273.02M | $ 134.40M | $ 15.85M | $ 569.39M |
| 2019 | $ 41.99M | $ -530.5K | $ 5.42M | $ 2.68M | $ 82.78M |
| 2018 | $ 28.21M | $ -5.93M | $ -4.63M | $ 0 | $ 52.27M |
| 2017 | $ 25.23M | $ -3.38M | $ -5.42M | $ 0 | $ 54.03M |
| 2016 | $ 25.14M | $ -7.36M | $ 848.9K | $ 0 | $ 54.48M |
| 2015 | $ 13.44M | $ -9.85M | $ -4.31M | $ 0 | $ 5.15M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 6.34 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.14 |
| Gross Debt / FCF | 0.11 |

## Other views

- [Metrics](https://sponda.capital/en/FLGT.md)
- [Charts](https://sponda.capital/en/FLGT/charts.md)
- [Compare](https://sponda.capital/en/FLGT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.